Literature DB >> 16101690

Transfusion practice in massively bleeding patients: time for a change?

P I Johansson1, M B Hansen, H Sørensen.   

Abstract

BACKGROUND AND OBJECTIVES: We identified some fatal cases where massively bleeding patients received inadequate transfusion therapy. The aim of this study was to review and evaluate the transfusion practice in acutely multitransfused patients.
MATERIALS AND METHODS: Patients receiving > 10 units of red blood cells (RBC) within 24 h of admission and 30 blood components within 7 days of admission were reviewed.
RESULTS: Thirty-nine patients were identified, 13 of whom were inadequately transfused (IT) and had a higher mortality (12/13) than adequately transfused (AT) patients 13/26 (P = 0.013). Ten of 13 IT patients developed a microvascular bleed compared to four of 26 in the AT group (P = 0.001) and had a lower platelet count upon arrival at the intensive care unit (40 x 10(9)/l vs. 80 x 10(9)/l, P = 0.024).
CONCLUSIONS: An early balanced transfusion therapy is vital in massively bleeding patients, and a pro-active approach from the blood bank is warranted. We have introduced an acute transfusion package (ATP) consisting of 5 RBC, 5 FFP and 2 PC units, indicated in massively bleeding patients, securing a balanced transfusion therapy.

Entities:  

Mesh:

Year:  2005        PMID: 16101690     DOI: 10.1111/j.1423-0410.2005.00668.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  15 in total

1.  Toward a definition of "fresh" whole blood: an in vitro characterization of coagulation properties in refrigerated whole blood for transfusion.

Authors:  David Jobes; Yanika Wolfe; Daniel O'Neill; Jennifer Calder; Lisa Jones; Deborah Sesok-Pizzini; X Long Zheng
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

2.  The transfusion problem: role of aberrant S-nitrosylation.

Authors:  James D Reynolds; Douglas T Hess; Jonathan S Stamler
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

3.  Trends in transfusion of trauma victims--evaluation of changes in clinical practice.

Authors:  Anders R Nakstad; Nils O Skaga; Johan Pillgram-Larsen; Berit Gran; Hans E Heier
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-04-11       Impact factor: 2.953

Review 4.  Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases.

Authors:  José Antonio García-Erce; Fernando Gomollón; Manuel Muñoz
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

5.  Blood Component Utilization for Disseminated Intravascular Coagulation (DIC) Cases with Respect to Underlying Condition.

Authors:  Snehalata C Gupte; Abhay G Jhaveri
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-25       Impact factor: 0.900

6.  Acute traumatic coagulopathy: Incidence, risk stratification and therapeutic options.

Authors:  Marc Maegele
Journal:  World J Emerg Med       Date:  2010

7.  S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood.

Authors:  James D Reynolds; Gregory S Ahearn; Michael Angelo; Jian Zhang; Fred Cobb; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-11       Impact factor: 11.205

8.  Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study.

Authors:  P I Johansson; J Stensballe
Journal:  Vox Sang       Date:  2009-02       Impact factor: 2.144

Review 9.  Thrombelastography and tromboelastometry in assessing coagulopathy in trauma.

Authors:  Pär I Johansson; Trine Stissing; Louise Bochsen; Sisse R Ostrowski
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-23       Impact factor: 2.953

10.  Recombinant factor VIIa: hemostatic adjunct in the coagulopathic burn patient.

Authors:  Jeremiah T Martin; Fuad Alkhoury; Bryan C McIntosh; Phillip Fidler; John Schulz
Journal:  Eplasty       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.